Hiroyuki Eda

1.2k total citations
37 papers, 994 citations indexed

About

Hiroyuki Eda is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Hiroyuki Eda has authored 37 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Hiroyuki Eda's work include Cancer, Hypoxia, and Metabolism (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Herpesvirus Infections and Treatments (5 papers). Hiroyuki Eda is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Herpesvirus Infections and Treatments (5 papers). Hiroyuki Eda collaborates with scholars based in Japan, United States and Switzerland. Hiroyuki Eda's co-authors include Hideo Ishitsuka, Kaori Fujimoto, Joseph B. Monahan, Masako Ura, Yutaka Tanaka, David Beidler, Shinichi Watanabe, Yutaka Tanaka, Hideaki Shimada and Kenji Wada and has published in prestigious journals such as Gastroenterology, Journal of Clinical Microbiology and International Journal of Cancer.

In The Last Decade

Hiroyuki Eda

36 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Eda Japan 17 409 347 204 195 185 37 994
Shoukang Zhu United States 17 592 1.4× 168 0.5× 396 1.9× 259 1.3× 198 1.1× 19 1.2k
Nathalie Belhacène France 20 620 1.5× 242 0.7× 76 0.4× 214 1.1× 125 0.7× 26 1.1k
Jack Leslie United Kingdom 17 396 1.0× 184 0.5× 102 0.5× 174 0.9× 208 1.1× 34 1.1k
Hao‐Chen Wang Taiwan 15 420 1.0× 342 1.0× 114 0.6× 253 1.3× 190 1.0× 30 934
Florence Mishellany France 17 195 0.5× 295 0.9× 99 0.5× 107 0.5× 217 1.2× 37 811
Jędrzej Grzegrzółka Poland 18 466 1.1× 427 1.2× 100 0.5× 140 0.7× 259 1.4× 76 1.1k
Christina Ravera United States 9 716 1.8× 554 1.6× 190 0.9× 94 0.5× 145 0.8× 15 1.3k
Amer M. Mirza United States 16 572 1.4× 316 0.9× 77 0.4× 334 1.7× 90 0.5× 32 1.3k
Christine Huard United States 13 648 1.6× 302 0.9× 68 0.3× 239 1.2× 108 0.6× 16 1.4k

Countries citing papers authored by Hiroyuki Eda

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Eda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Eda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Eda more than expected).

Fields of papers citing papers by Hiroyuki Eda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Eda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Eda. The network helps show where Hiroyuki Eda may publish in the future.

Co-authorship network of co-authors of Hiroyuki Eda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Eda. A scholar is included among the top collaborators of Hiroyuki Eda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Eda. Hiroyuki Eda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugiura, Toshihiko, Shunsuke Kageyama, Ayatoshi Andou, et al.. (2013). Oral treatment with a novel small molecule alpha 4 integrin antagonist, AJM300, prevents the development of experimental colitis in mice. Journal of Crohn s and Colitis. 7(11). e533–e542. 52 indexed citations
2.
Eda, Hiroyuki, Katherine M. Kulig, Hideaki Shimada, et al.. (2012). A Nanofiber Membrane Maintains the Quiescent Phenotype of Hepatic Stellate Cells. Digestive Diseases and Sciences. 57(5). 1152–1162. 3 indexed citations
3.
Eda, Hiroyuki, Hideaki Shimada, David Beidler, & Joseph B. Monahan. (2010). Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts. Rheumatology International. 31(11). 1525–1530. 87 indexed citations
4.
Mnich, Stephen J., Alexander F. Shaffer, Shawn P. O’Neil, et al.. (2010). Critical role for apoptosis signal-regulating kinase 1 in the development of inflammatory K/BxN serum-induced arthritis. International Immunopharmacology. 10(10). 1170–1176. 31 indexed citations
5.
Eda, Hiroyuki, Jian Zhang, Robert H. Keith, et al.. (2010). Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood. Cytokine. 52(3). 215–220. 65 indexed citations
6.
7.
Sugimoto, Hiromi, et al.. (2009). In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT4 receptor. European Journal of Pharmacology. 609(1-3). 5–12. 4 indexed citations
8.
Kojima, Midori, Naoto Kato, Daisuke Hirano, et al.. (2008). Selective CB1 cannabinoid receptor antagonist, SR141716A, attenuates liver injury induced by Concanavalin A. Hepatology Research. 39(4). 408–414. 5 indexed citations
9.
10.
Sugimoto, Hiromi, et al.. (2008). Contribution of Active and Inactive States of the Human 5-HT4d Receptor to the Functional Activities of 5-HT4–Receptor Agonists. Journal of Pharmacological Sciences. 107(3). 251–259. 8 indexed citations
11.
Yamamoto, Mitsuko L., Naoto Kato, Midori Kojima, et al.. (2007). Orally-Administered Caspase Inhibitor PF-03491390 Is Retained in the Liver for Prolonged Periods With Low Systemic Exposure, Exerting a Hepatoprotective Effect Against α-Fas-Induced Liver Injury in a Mouse Model. Journal of Pharmacological Sciences. 105(2). 201–205. 18 indexed citations
12.
Ito, Sadayoshi, et al.. (2003). Epstein-Barr virus nuclear antigen-1 colocalizes with lamin B1 in the nucleoplasm and along the nuclear rim. Archives of Virology. 148(8). 1633–1642. 2 indexed citations
13.
Hattori, Kazuo, Yasunori Kohchi, Nobuhiro Oikawa, et al.. (2003). Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine. Bioorganic & Medicinal Chemistry Letters. 13(5). 867–872. 22 indexed citations
14.
Endo, Mika, Masanori Miwa, Hiroyuki Eda, et al.. (2003). Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889. International Journal of Cancer. 106(5). 799–805. 8 indexed citations
15.
Mitsuhashi, Akira, et al.. (1998). Establishment and Characterization of a New HPV-Negative Squamous Cell Carcinoma Cell Line (Yumoto) from the Human Uterine Cervix. Gynecologic Oncology. 70(3). 339–347. 14 indexed citations
16.
Eda, Hiroyuki, Kaori Fujimoto, Shinichi Watanabe, et al.. (1993). Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5?-deoxy-5-fluorouridine. Cancer Chemotherapy and Pharmacology. 32(5). 333–338. 190 indexed citations
17.
Eda, Hiroyuki, Kaori Fujimoto, Shinichi Watanabe, et al.. (1993). Cytokines Induce Uridine Phosphorylase in Mouse Colon 26 Carcinoma Cells and Make the Cells More Susceptible to 5′‐Deoxy‐5‐fluorouridine. Japanese Journal of Cancer Research. 84(3). 341–347. 41 indexed citations
18.
Eda, Hiroyuki, Yutaka Tanaka, & Hideo Ishitsuka. (1991). 5?-Deoxy-5-fluorouridine improves cachexia by a mechanism independent of its antiproliferative action in colon 26 adenocarcinoma-bearing mice. Cancer Chemotherapy and Pharmacology. 29(1). 1–6. 8 indexed citations
19.
Miwa, Masanori, Hiroyuki Eda, Hiroshi Sahara, et al.. (1990). Comparative Antitumor Activity and Intestinal Toxicity of 5′‐Deoxy‐5‐fluorouridine and Its Prodrug Trimethoxybenzoyl‐5′‐deoxy‐5‐fluorocytidine. Japanese Journal of Cancer Research. 81(2). 188–195. 30 indexed citations
20.
Yoshino, Kamesaburo, et al.. (1989). Localization of a Variant of Herpes Simplex Virus Type 1 in the Western Japan. Kansenshogaku zasshi. 63(1). 39–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoukang Zhu Breakdown of academic impact, for papers by Nathalie Belhacène Breakdown of academic impact, for papers by Jack Leslie Breakdown of academic impact, for papers by Hao‐Chen Wang Breakdown of academic impact, for papers by Florence Mishellany Breakdown of academic impact, for papers by Jędrzej Grzegrzółka Breakdown of academic impact, for papers by Christina Ravera Breakdown of academic impact, for papers by Amer M. Mirza Breakdown of academic impact, for papers by Christine Huard
Rankless by CCL
2026